There’s a lack of proof to back up the peptides hype AFRUS health panel recommends easing restrictions on controversial peptides The GuardianFDA panel, with ties to the peptide industry, recommends easing restrictions on four of the compounds NBC NewsRFK Jr. promised to stop the ‘aggressive suppression’ of these controversial drugs. He’s making progress. PoliticoWhat’s the deal with peptides? The hyped market under US review News.com.au
